Mabwell Presents Clinical Results of Nectin-4-Targeting ADC 9MW2821 at 2026 ESMO Gynaecological Cancers Congress Written by PR Newswire Enable JavaScript and cookies to continueimage1.jpg?p=medium600#Read more http://www.prnasia.com/story/archive/4987224_CN87224_0